Clinical Trial Update: Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization

View source ↗

Summary

Cidara Therapeutics (a Merck subsidiary) conducted a non-interventional extension to study recurrence of vulvovaginal candidiasis and Candida colonization. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Snippet

Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Candidiasis, Vulvovaginal, Yeast Infection | Status: COMPLETED